Historique
Rapport
Science and technology - ninth report
Auteur(s) :
House of Lords
Année
1998
Page(s) :
63 p.
Langue(s) :
Anglais
Domaine :
Drogues illicites / Illicit drugs
Discipline :
PRO (Produits, mode d'action, méthode de dépistage / Substances, action mode, screening methods)
Thésaurus géographique
ROYAUME-UNI
Thésaurus mots-clés
TECHNOLOGIE
;
CANNABIS
;
HISTOIRE
;
CONSOMMATION
;
TYPE D'USAGE
;
PHARMACOLOGIE
;
EFFET SECONDAIRE
;
TOLERANCE
;
DEPENDANCE
;
USAGE THERAPEUTIQUE
;
USAGE RECREATIF
;
LEGISLATION
;
CANNABINOIDES
;
TOXICITE
Note de contenu :
1. INTRODUCTION.
2. HISTORY OF THE USE OF CANNABIS.
3. PHARMACOLOGY OF CANNABIS AND THE CANNABINOIDS.
4. TOXIC EFFECTS OF CANNABISAND CANNABINOIDS: REVIEW OF THE EVIDENCE.
5. MEDICAL USE OF CANNABIS AND CANNABINOIDS: REVIEW OF THE EVIDENCE:
Current medical use of cannabis; Advice to medical users; Current medical uses of cannabinoids; Proposed new indications for cannabis-based medicines; Multiple sclerosis; Pain; Epilepsy; Glaucoma; Bronchial asthma; Need for clinical trials of cannabis and cannabinoids; Should clinical trials be limited to cannabinoids?; Should clinical trials include smoking?
6. RECREATIONAL USE OF CANNABIS:
Prevalence; Pattern of use; Content of cannabis consumed in the United Kingdom; The state of the law.
7. CHANGING THE LAW ON MEDICAL USE AND RESEARCH: REVIEW OF THE EVIDENCE:
Prosecution for use of cannabis for medical purposes; Possible transfer from Schedule 1 to Schedule 2; Research; Medical use and recreational use.
8. OPINION OF THE COMMITTEE:
Medical use of cannabis: recommendations; Medical use of cannabinoids: recommendations; Why change the law?; Recreational use; Summary of recommendations.
2. HISTORY OF THE USE OF CANNABIS.
3. PHARMACOLOGY OF CANNABIS AND THE CANNABINOIDS.
4. TOXIC EFFECTS OF CANNABISAND CANNABINOIDS: REVIEW OF THE EVIDENCE.
5. MEDICAL USE OF CANNABIS AND CANNABINOIDS: REVIEW OF THE EVIDENCE:
Current medical use of cannabis; Advice to medical users; Current medical uses of cannabinoids; Proposed new indications for cannabis-based medicines; Multiple sclerosis; Pain; Epilepsy; Glaucoma; Bronchial asthma; Need for clinical trials of cannabis and cannabinoids; Should clinical trials be limited to cannabinoids?; Should clinical trials include smoking?
6. RECREATIONAL USE OF CANNABIS:
Prevalence; Pattern of use; Content of cannabis consumed in the United Kingdom; The state of the law.
7. CHANGING THE LAW ON MEDICAL USE AND RESEARCH: REVIEW OF THE EVIDENCE:
Prosecution for use of cannabis for medical purposes; Possible transfer from Schedule 1 to Schedule 2; Research; Medical use and recreational use.
8. OPINION OF THE COMMITTEE:
Medical use of cannabis: recommendations; Medical use of cannabinoids: recommendations; Why change the law?; Recreational use; Summary of recommendations.
Affiliation :
UK